We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

AXP:NYSEAmerican Express Company Analysis

Data as of 2026-03-09 - not real-time

$305.38

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

American Express is trading at $305.38, well below the DCF‑derived fair value of $382, implying roughly a 23% upside and positioning the stock as undervalued. The company delivers solid fundamentals – 10.6% revenue growth, a 34% ROE and a forward PE of 15.2 versus the industry average of 17.4 – suggesting a growth‑oriented profile despite its mature financial‑services niche. The dividend payout ratio sits at just 21% with a 1.26% yield, indicating the payout is comfortably sustainable. Recent news highlights a projected 9‑10% revenue increase for 2026, reinforcing earnings momentum, while analyst sentiment remains bullish with a consensus “Buy” and a mean target price near $377.
Technical indicators show the stock near its 20‑day SMA and just above the identified support level of $292.5, with RSI at 33 pointing to oversold conditions and a bearish‑crossing MACD that may be nearing a turnaround as volume trends upward. The high beta of 1.33 and 30‑day volatility above 38% flag price swing risk, yet the strong balance sheet, global footprint and resilient brand mitigate sector and regulatory concerns. Overall, the blend of valuation upside, earnings growth, and dividend safety supports a positive outlook across horizons.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Oversold RSI indicating near‑term price floor
  • Current price above key support with increasing volume
  • Positive revenue growth outlook for 2026

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued relative to DCF fair value
  • Strong ROE and forward PE advantage versus peers
  • Sustainable dividend providing income cushion

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Brand moat and global network in credit services
  • Consistent earnings growth and high cash generation
  • Long‑term dividend yield and modest payout ratio

Key Metrics & Analysis

Financial Health

Revenue Growth10.60%
Profit Margin16.17%
P/E Ratio19.9
ROE33.99%
ROA3.79%
Debt/Equity190.92
P/B Ratio6.3
Op. Cash Flow$18.4B
Industry P/E17.4

Technical Analysis

TrendNeutral
RSI33.5
Support$292.50
Resistance$369.50
MA 20$329.50
MA 50$350.91
MA 200$334.88
MACDBearish
VolumeIncreasing
Fear & Greed Index100

Valuation

Fair Value$382.14
Target Price$377.28
Upside/Downside23.55%
GradeUndervalued
TypeBlend
Dividend Yield1.26%

Risk Assessment

Beta1.34
Volatility38.36%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.